Compare · ISRG vs POAI
ISRG vs POAI
Side-by-side comparison of Intuitive Surgical Inc. (ISRG) and Predictive Oncology Inc. (POAI): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both ISRG and POAI operate in Industrial Specialties (Health Care), so they compete in similar markets.
- ISRG is the larger of the two at $151.09B, about 12178.5x POAI ($12.4M).
- Over the past year, ISRG is down 19.4% and POAI is down 61.1% - ISRG leads by 41.6 points.
- ISRG has hit the wire 7 times in the past 4 weeks while POAI has been quiet.
- ISRG has more recent analyst coverage (25 ratings vs 2 for POAI).
- Company
- Intuitive Surgical Inc.
- Predictive Oncology Inc.
- Price
- $426.60+1.92%
- $5.49-0.18%
- Market cap
- $151.09B
- $12.4M
- 1M return
- -5.18%
- -16.18%
- 1Y return
- -19.44%
- -61.06%
- Industry
- Industrial Specialties
- Industrial Specialties
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2000
- News (4w)
- 7
- 0
- Recent ratings
- 25
- 2
Intuitive Surgical Inc.
Intuitive Surgical, Inc., together with its subsidiaries, designs, develops, manufactures, and markets da Vinci surgical systems, and related instruments and accessories in the United States and internationally. The company's da Vinci Surgical System include surgeon's consoles, patient-side carts, 3-D HD vision systems, skills simulators, da Vinci Xi integrated table motions, and Firefly fluorescence imaging products that enable surgeons to perform various surgical procedures, including gynecologic, urologic, general, cardiothoracic, and head and neck surgical procedures. It also manufactures EndoWrist instruments, such as forceps, scissors, electrocautery tools, scalpels, and other surgical tools, which incorporate wrist joints for natural dexterity for various surgical procedures; and provides SimNow, a cloud-enabled simulation platform, which allows surgeons to learn and practice their surgical skills; Iris, an augmented reality imaging product for use in kidney procedures; and Intuitive Cloud that enables proactive monitoring and software updates. In addition, the company offers EndoWrist Stapler, a wristed stapling instrument for resection, transection, and creation of anastomoses; EndoWrist One Vessel Sealers that are wristed single-use instruments for bipolar coagulation and mechanical transection of vessels up to 7mm in diameter and tissue bundles that fit in the jaws of the instrument; E-100 generator, an electrosurgical generator; SureForm 45 Curved-Tip stapler; and SynchroSeal for sealing and transection with a single pedal press. Additionally, the company sells various accessories comprising sterile drapes for ensuring sterile field during surgery; and vision products that include replacement 3D stereo endoscopes, camera heads, light guides, and other items that facilitate the use of the da Vinci Surgical System, as well as Ion endoluminal system for biopsies. Intuitive Surgical, Inc. was founded in 1995 and is headquartered in Sunnyvale, California.
Predictive Oncology Inc.
Predictive Oncology Inc. provides various healthcare products and services primarily in the United States. The company operates in three segments: Helomics, Soluble, and Skyline. The company manufactures environmentally conscious systems for the collection and disposal of infectious fluids that result from surgical procedures and post-operative care. It offers STREAMWAY System, a wall-mounted fully automated system that disposes suction fluid providing uninterrupted performance for physicians while virtually eliminating healthcare workers' exposure to infectious fluids collected during surgical and other patient procedures, as well as proprietary cleaning fluid and filters to users of its systems. The company also provides contract research organization (CRO) and AI-driven predictive models of tumor drug response to improve clinical outcomes to assist pharmaceutical, diagnostic, and biotech industries; and soluble and stable formulations for proteins, including vaccines, antibodies, and other protein therapeutics, as well as develops tumor models for precision cancer therapy and drug development. Its CRO services enhance the effectiveness of cancer therapy using the power of artificial intelligence (AI) applied to diseases databases. The company sells its medical device products directly to hospitals and other medical facilities through employed sales representatives, independent contractors, and distributors. The company was formerly known as Precision Therapeutics Inc. and changed its name to Predictive Oncology Inc. in June 2019. Predictive Oncology Inc. was incorporated in 2002 and is based in Eagan, Minnesota.
Latest ISRG
- SVP & GM da Vinci Platforms & Jeddi Iman sold $2,365,594 worth of shares (5,625 units at $420.55) as part of a pre-agreed trading plan and exercised 5,625 shares at a strike of $77.00 (SEC Form 4)
- Intuitive Surgical Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits
- Intuitive Announces New Chief Commercial and Marketing Officer Taylor Patton
- EVP & Chief Mfg and Supply Cha Brosius Mark sold $15,945 worth of shares (36 units at $442.92) as part of a pre-agreed trading plan, decreasing direct ownership by 2% to 1,523 units (SEC Form 4)
- SEC Form SD filed by Intuitive Surgical Inc.
- Intuitive Announces Innovations to Advance Quintuple Aim
- EVP & Chief Mfg and Supply Cha Brosius Mark sold $23,464 worth of shares (54 units at $434.52) as part of a pre-agreed trading plan, decreasing direct ownership by 3% to 1,559 units (SEC Form 4)
- EVP & Chief Legal and Complian Loeb Gary sold $178,780 worth of shares (400 units at $446.95) as part of a pre-agreed trading plan, decreasing direct ownership by 6% to 6,120 units (SEC Form 4)
- Intuitive Surgical Inc. filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders, Regulation FD Disclosure, Financial Statements and Exhibits
- SEC Form 4 filed by Director Guthart Gary S
Latest POAI
- SEC Form S-8 filed by Predictive Oncology Inc.
- Predictive Oncology Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits
- Chief Executive Officer Vennare Raymond F covered exercise/tax liability with 2,373 shares, decreasing direct ownership by 27% to 6,418 units (SEC Form 4)
- Predictive Oncology Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
- Predictive Oncology Regains Compliance with Nasdaq's Minimum Stockholders' Equity Requirement
- SEC Form EFFECT filed by Predictive Oncology Inc.
- Predictive Oncology Inc. filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits
- SEC Form 424B3 filed by Predictive Oncology Inc.
- SEC Form 424B3 filed by Predictive Oncology Inc.
- Predictive Oncology Inc. filed SEC Form 8-K: Other Events